Sexual minority disparities in opioid and benzodiazepine misuse among adults with opioid use disorder.
Journal
The American journal on addictions
ISSN: 1521-0391
Titre abrégé: Am J Addict
Pays: England
ID NLM: 9208821
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
17
12
2021
received:
14
09
2021
accepted:
03
01
2022
pubmed:
5
3
2022
medline:
20
5
2022
entrez:
4
3
2022
Statut:
ppublish
Résumé
Sexual minority individuals demonstrate disparate rates of substance use. Research suggests that bisexual women are vulnerable to substance use disorders when compared to other sexual minority groups. This study explored differences in prevalence of past-year alcohol use disorder (AUD) with and without concurrent past-year opioid and/or benzodiazepine misuse. The present study utilized responses from the National Survey on Drug Use and Health (NSDUH) public dataset between the years 2015-2019 (N = 16,002) to examine the association between sexual orientation and concurrent misuse of opioids and/or benzodiazepines among individuals with past-year AUD, stratified by sex. Bisexual females demonstrated higher rates of concurrent opioid and benzodiazepine use compared to all other groups. Although there was no association between sexual orientation and concurrent substance use patterns among males, female respondents with past-year AUD endorsing past-year misuse of opioids and benzodiazepines, both alone and in combination, were more likely to be bisexual compared to heterosexual. Lesbians were less likely to endorse concurrent misuse of opioids and benzodiazepines compared to bisexual females. In a national sample, bisexual females demonstrated higher odds of risky concurrent substance use patterns. Identifying sexual minority individuals who exhibit elevated risk of co-occurring alcohol, opioid, and/or benzodiazepine misuse is an important step to targeted prevention efforts and allocation of resources to combat rising overdose deaths. For the first time, this study explored risky concurrent alcohol, opioid, and benzodiazepine misuse patterns among individuals of different sexual orientations.
Sections du résumé
BACKGROUND AND OBJECTIVES
Sexual minority individuals demonstrate disparate rates of substance use. Research suggests that bisexual women are vulnerable to substance use disorders when compared to other sexual minority groups. This study explored differences in prevalence of past-year alcohol use disorder (AUD) with and without concurrent past-year opioid and/or benzodiazepine misuse.
METHODS
The present study utilized responses from the National Survey on Drug Use and Health (NSDUH) public dataset between the years 2015-2019 (N = 16,002) to examine the association between sexual orientation and concurrent misuse of opioids and/or benzodiazepines among individuals with past-year AUD, stratified by sex.
RESULTS
Bisexual females demonstrated higher rates of concurrent opioid and benzodiazepine use compared to all other groups. Although there was no association between sexual orientation and concurrent substance use patterns among males, female respondents with past-year AUD endorsing past-year misuse of opioids and benzodiazepines, both alone and in combination, were more likely to be bisexual compared to heterosexual. Lesbians were less likely to endorse concurrent misuse of opioids and benzodiazepines compared to bisexual females.
DISCUSSION AND CONCLUSIONS
In a national sample, bisexual females demonstrated higher odds of risky concurrent substance use patterns. Identifying sexual minority individuals who exhibit elevated risk of co-occurring alcohol, opioid, and/or benzodiazepine misuse is an important step to targeted prevention efforts and allocation of resources to combat rising overdose deaths.
SCIENTIFIC SIGNIFICANCE
For the first time, this study explored risky concurrent alcohol, opioid, and benzodiazepine misuse patterns among individuals of different sexual orientations.
Identifiants
pubmed: 35243706
doi: 10.1111/ajad.13258
pmc: PMC9117396
mid: NIHMS1769543
doi:
Substances chimiques
Analgesics, Opioid
0
Benzodiazepines
12794-10-4
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
200-209Subventions
Organisme : NIAAA NIH HHS
ID : P01 AA027473
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA037202
Pays : United States
Organisme : NIAAA NIH HHS
ID : U54 AA027989
Pays : United States
Informations de copyright
© 2022 American Academy of Addiction Psychiatry.
Références
Am J Prev Med. 2019 Aug;57(2):197-208
pubmed: 31200998
Pediatrics. 1998 May;101(5):895-902
pubmed: 9565422
BMC Public Health. 2014 Dec 18;14:1297
pubmed: 25519144
Addiction. 2008 Apr;103(4):546-56
pubmed: 18339100
JAMA. 2021 Feb 9;325(6):523
pubmed: 33560330
Drug Alcohol Depend. 2020 Jan 1;206:107755
pubmed: 31810051
Subst Use Misuse. 2018 Jun 7;53(7):1221-1228
pubmed: 29236561
Int J Drug Policy. 2015 Jan;26(1):84-91
pubmed: 25151334
Alcohol Res. 2016;38(1):121-32
pubmed: 27159819
Curr Pharm Des. 2012;18(37):5994-6004
pubmed: 22747535
Psychiatr Serv. 2019 Feb 1;70(2):97-106
pubmed: 30554562
Natl Vital Stat Rep. 2016 Dec;65(10):1-15
pubmed: 27996932
Drug Alcohol Depend. 2019 Aug 1;201:78-84
pubmed: 31200278
Drug Alcohol Depend. 2013 Sep 1;132(1-2):391-4
pubmed: 23510637
Psychol Bull. 2003 Sep;129(5):674-697
pubmed: 12956539
JAMA Netw Open. 2020 Apr 1;3(4):e202361
pubmed: 32271389
J Subst Abuse. 2000;11(2):139-47
pubmed: 10989774
J Addict Dis. 2001;20(4):53-69
pubmed: 11760926
J Subst Abuse Treat. 2020 Oct;117:108061
pubmed: 32811622
Drug Alcohol Depend. 2005 Oct 1;80(1):105-16
pubmed: 16157233
Addiction. 2009 Aug;104(8):1333-45
pubmed: 19438839
Alcohol Clin Exp Res. 2018 Mar;42(3):478-488
pubmed: 29314075
JAMA Psychiatry. 2017 Sep 1;74(9):911-923
pubmed: 28793133
JAMA. 2013 Feb 20;309(7):657-9
pubmed: 23423407
Drug Alcohol Depend. 2021 Jan 1;218:108350
pubmed: 33121867
Postgrad Med. 2013 Jul;125(4):115-30
pubmed: 23933900